18-46577809-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001384474.1(LOXHD1):c.1868G>A(p.Arg623Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000657 in 1,551,690 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001384474.1 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 77Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Fuchs' endothelial dystrophyInheritance: AD Classification: LIMITED Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LOXHD1 | NM_001384474.1 | c.1868G>A | p.Arg623Lys | missense_variant | Exon 14 of 41 | ENST00000642948.1 | NP_001371403.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LOXHD1 | ENST00000642948.1 | c.1868G>A | p.Arg623Lys | missense_variant | Exon 14 of 41 | NM_001384474.1 | ENSP00000496347.1 | |||
| LOXHD1 | ENST00000536736.5 | c.1868G>A | p.Arg623Lys | missense_variant | Exon 14 of 40 | 5 | ENSP00000444586.1 | |||
| LOXHD1 | ENST00000441551.6 | c.1868G>A | p.Arg623Lys | missense_variant | Exon 14 of 39 | 5 | ENSP00000387621.2 | |||
| LOXHD1 | ENST00000335730.6 | n.1181G>A | non_coding_transcript_exon_variant | Exon 7 of 27 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000375 AC: 57AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000948 AC: 15AN: 158182 AF XY: 0.0000360 show subpopulations
GnomAD4 exome AF: 0.0000322 AC: 45AN: 1399422Hom.: 1 Cov.: 31 AF XY: 0.0000203 AC XY: 14AN XY: 690216 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000374 AC: 57AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74454 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 77 Uncertain:2
- -
- -
not specified Uncertain:1
The Arg623Lys variant in LOXHD1 has not been previously reported in individuals with hearing loss, but has been identified in 0.1% (2/1384) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/ EVS/; dbSNP rs373151735). Computational prediction tools and conservation analys es suggest that the Arg623Lys variant may not impact the protein, though this in formation is not predictive enough to rule out pathogenicity. In summary, the cl inical significance of the Arg623Lys variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.1868G>A (p.R623K) alteration is located in exon 14 (coding exon 14) of the LOXHD1 gene. This alteration results from a G to A substitution at nucleotide position 1868, causing the arginine (R) at amino acid position 623 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 623 of the LOXHD1 protein (p.Arg623Lys). This variant is present in population databases (rs373151735, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with LOXHD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 163922). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at